Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2022 Apr 21;186(6):G9-G49.
doi: 10.1530/EJE-22-0073.

Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline

A Nordenström  1 , S F Ahmed  2 , E van den Akker  3 , J Blair  4 , M Bonomi  5   6 , C Brachet  7 , L H A Broersen  8 , H L Claahsen-van der Grinten  9 , A B Dessens  10   11 , A Gawlik  12 , C H Gravholt  13   14 , A Juul  15   16 , C Krausz  17 , T Raivio  18 , A Smyth  19 , P Touraine  20   21 , D Vitali  22 , O M Dekkers  23   24
Affiliations
Practice Guideline

Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline

A Nordenström et al. Eur J Endocrinol. .

Abstract

An Endo-European Reference Network guideline initiative was launched including 16 clinicians experienced in endocrinology, pediatric and adult and 2 patient representatives. The guideline was endorsed by the European Society for Pediatric Endocrinology, the European Society for Endocrinology and the European Academy of Andrology. The aim was to create practice guidelines for clinical assessment and puberty induction in individuals with congenital pituitary or gonadal hormone deficiency. A systematic literature search was conducted, and the evidence was graded according to the Grading of Recommendations, Assessment, Development and Evaluation system. If the evidence was insufficient or lacking, then the conclusions were based on expert opinion. The guideline includes recommendations for puberty induction with oestrogen or testosterone. Publications on the induction of puberty with follicle-stimulation hormone and human chorionic gonadotrophin in hypogonadotropic hypogonadism are reviewed. Specific issues in individuals with Klinefelter syndrome or androgen insensitivity syndrome are considered. The expert panel recommends that pubertal induction or sex hormone replacement to sustain puberty should be cared for by a multidisciplinary team. Children with a known condition should be followed from the age of 8 years for girls and 9 years for boys. Puberty induction should be individualised but considered at 11 years in girls and 12 years in boys. Psychological aspects of puberty and fertility issues are especially important to address in individuals with sex development disorders or congenital pituitary deficiencies. The transition of these young adults highlights the importance of a multidisciplinary approach, to discuss both medical issues and social and psychological issues that arise in the context of these chronic conditions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of included papers.
Figure 2
Figure 2
Oral-conjugated oestrogen vs transdermal 17β oestradiol for reaching Tanner stage B3. Yes denotes having reached Tanner stage 3; no denotes having not reached Tanner stage 3: the risk ratio expresses the probability ratio for reaching Tanner stage B3.
Figure 3
Figure 3
Oestrogen as add-on therapy for final height.
Figure 4
Figure 4
Early (age 10–12 years) and late (from age 12 years) start of oestrogen for final height.
Figure 5
Figure 5
Early (age 10–12 years) and late (from age 12 years) start of oestrogen for BMI.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocrine Reviews 200324668–693. (10.1210/er.2002-0019) - DOI - PubMed
    1. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood 196944291–303. (10.1136/adc.44.235.291) - DOI - PMC - PubMed
    1. Sørensen K, Aksglaede L, Petersen JH, Juul A. Recent changes in pubertal timing in healthy Danish boys: associations with body mass index. Journal of Clinical Endocrinology and Metabolism 201095263–270. (10.1210/jc.2009-1478) - DOI - PubMed
    1. Sørensen K, Mouritsen A, Aksglaede L, Hagen CP, Mogensen SS, Juul A. Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty. Hormone Research in Paediatrics 201277137–145. (10.1159/000336325) - DOI - PubMed
    1. Taranger J, Engström I, Lichtenstein H, Svennberg- Redegren I. VI. Somatic pubertal development. Acta Paediatrica 197665 (S258)121–135. (10.1111/j.1651-2227.1976.tb14766.x) - DOI - PubMed

Publication types